期刊文献+

高糖对大鼠心肌成纤维细胞UⅡ及其受体表达影响 被引量:1

EFFCTS OF HIGH GLUCOSE ON THE EXPRESSION OF UROTENSIN Ⅱ AND ITS RECEPTOR IN CARDIAC FIBROBLASTS
下载PDF
导出
摘要 目的探讨高糖对大鼠心肌成纤维细胞尾加压素Ⅱ(UⅡ)及其受体(UT)表达的影响。方法体外培养新生Wistar大鼠乳鼠的心肌成纤维细胞,随机分为正常对照组、高渗对照组、高糖组,3组细胞分别采用含5.5mmol/L葡萄糖、5.5mmol/L葡萄糖+19.5mmol/L甘露醇、25.0mmol/L葡萄糖的培养液培养48h后,应用免疫荧光法、免疫印迹法检测UⅡ及UT的表达。结果高糖组UⅡ和UT表达量明显高于正常对照组和高渗对照组,差异有显著意义(F=15.08~192.20,q=3.75~30.00,P〈0.05)。结论大鼠心肌成纤维细胞中存在UⅡ及UT表达,并且高糖刺激可使两者表达增强。 Objective To explore the effects of high glucose on the expressions of urotensinⅡ(UⅡ)and its receptor in cardiac fibroblasts. Methods The cardiac fibroblasts of neonatal Wistar rats were cultured in vitro and randomized to normal control group,hypertonic control group and high glucose group.The cells in the three groups were cultured with glucose 5.5mmol/L,glucose 5.5mmol/L+mannitol 19.5mmol/L and glucose 25.0mmol/L for 48 h,respectively.Immunofluorescence and Western bloting were used to detect the expressions of UⅡ and its receptor. Results Immumofluorescence and Western blotting analysis showed that the expressions of UⅡ and its receptor in high glucose group were higher than that in normal control and hypertonic control(F=15.08-192.20,q=3.75-30.00,P0.05). Conclusion Expressions of urotensinⅡ and its receptor exist in rat cardiac fibroblasts,and both expressions can be enhanced by high-glucose stimulation.
出处 《青岛大学医学院学报》 CAS 2015年第4期395-397,400,共4页 Acta Academiae Medicinae Qingdao Universitatis
基金 国家自然科学基金(81200175) 青岛市科技局科研基金(2012-1-3-1-(2)-nsh)资助项目
关键词 糖尿病心肌病 心肌 成纤维细胞 尾加压素Ⅱ 受体 尾加压素Ⅱ diabetic cardiomyopathies cardiac fibroblasts urotensin Ⅱ receptor urotensin Ⅱ
  • 相关文献

参考文献17

  • 1NICHOLS G A, HILLIER T A, ERBEY J R, et al. Conges- tive heart failure in type 2 diabetes--prevalence, incidence, and risk factors[J]. Diabetes Care, 2001,24(9) : 1614-1619.
  • 2MIZUSHIGE K, YAO L, NOMA T, et al. Alteration in left ventricular diastolic filling and accumulation of myocardial col- lagen at insulin-resistant prediabetic stage of a type II diabetic rat model[J]. Circulation, 2000,101 (8) : 899-907.
  • 3ROSS B, MCKENDY K, GIAID A. Role of urotensin ]l in health and disease[J]. American Journal of Physiology-Regula- tory Integrative and Comparative Physiology, 2010,298 (5): Rl156-R1172.
  • 4TZANIDIS A, HANNAN R D, THOMAS W G, et al. Direc- tactions of urotensin [I on the heart., implications for cardiac fibrosis and hypertrophy[J]. Circulation Research, 2003, 93 (3) :246-253.
  • 5BOUSETTE N, HU F, OHLSTEIN E H, et al. Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation[J]. Journal of Molecular and Cellular Cardiology, 2006,41(2) ;285-295.
  • 6LANGHAM R G, KELLY D J, GOW R M, et al. Increased expression of urotensin 1][ and urotensin n receptor in human diabetic nephropathy[J]. American Journal of Kidney Disea- ses: the Official Journal of the National Kidney Foundation, 2004,44(5) : 826-831.
  • 7TIAN L, LI C, QI J P, et al. Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF- betal-mediated renal fibrosis and dysfunction [J]. American Journal of Physiology-Endocrinology and Metabolism, 2008, 295(5) : E1234-E1242.
  • 8CLOZEL M, HESS P, QIU C B, et al. The urotensin-H re- cePtor antagonist palosuran improves pancreatic and renal function in diabetic rats[J]. The Journal of Pharmacology and Experimental Therapeutics, 2006,316(3) :1115-1121.
  • 9DAI H Y, GUO X G, GE Z M, et al. Elevated expression of urotensin and its receptor in diabetic cardiomyopathy[J]. Journal of Diabetes and Its Complications, 2008,22 (2):137- 143.
  • 10杨蓉,常亮,刘金明,王梅,刘素云,李拥军.罗格列酮对高糖刺激下新生大鼠心脏成纤维细胞胶原表达的调节[J].中国医院药学杂志,2013,33(9):703-706. 被引量:1

二级参考文献52

  • 1李长运,曹林生,曾秋棠.黄芪注射液下调血管紧张素II受体2型的表达保护糖尿病心肌病大鼠的观察[J].中日友好医院学报,2004,18(6):350-353. 被引量:11
  • 2郭晏同,冷希圣,李涛,宋盛晗,秦致中,熊亮发.过氧化物酶体增殖物活化的受体γ特异配体罗格列酮对肝星状细胞生物学特性的影响[J].解剖学报,2005,36(2):150-153. 被引量:26
  • 3张勇刚 杨军 等.尾加压素Ⅱ在心血管系统中的作用[J].北京医科大学学报,2000,32(2):133-133.
  • 4DAVIDOFF A J, REN J. Low insulin and high glucose induces abnormal relaxation in cultured adult rat ventricular myocytes[J]. Am J Physiol, 1997, 272: H159-167.
  • 5PANCHAPAKESAN U, SUMUAL S, POLLOCK C A, et al. PPARgamma agonist exert antifibrotic effects in renal tubular cells exposed to high glucose [J]. Am J Physiol Renal Physiol, 2005, 289:F1153-1158.
  • 6VAN WESTERLOO D J, FLORQUIN S, DE BOER A M, et al. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice [ J]. Am J Pathol, 2005,166: 721-728.
  • 7HAZRA S, XIONG S, WANG J, et al. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from active to quiescent hepatic stellate cells[J]. J Biol Chem, 2004, 279: 11392-11401.
  • 8SIMPSON P, MCGRATH A, SAVION S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines[J]. Circ Res, 1982, 51: 787-801.
  • 9ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy[J]. N EnglJ Med, 2006, 355:2427-2443.
  • 10NEGRO R, DAZZI D, HASSAN H, et al. Pioglitazone reduces blood pressure in non-dipping diabetic patients[J]. Minerva Endocrinol, 2004, 29 : 11 - 17.

共引文献78

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部